Daito Pharmaceutical Co., Ltd. Financial Overview
Daito Pharmaceutical Co., Ltd.'s market cap is currently ¥40.83B. The company's EPS TTM is ¥23.24; its P/E ratio is 20.65; and it has a dividend yield of 2.77%. Daito Pharmaceutical Co., Ltd. is scheduled to report earnings on October 10, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
